A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sention Therapeutics, LLC
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed with primary hypothyroidism
On continuous thyroid replacement therapy with levothyroxine for at least 12 months immediately prior to Screening
On a stable daily dose of levothyroxine for the 3 months prior to Screening
Willing to give written informed consent for the Study
You may not be if
Any clinical condition or previous surgery that might affect the absorption, distribution, biotransformation or excretion of ST-1891 or levothyroxine
Female patients who are pregnant or are breastfeeding starting 30 days prior to Screening
Anticipated initiation or change in concomitant medications
Concomitant use of prohibited medications
Currently participating in another clinical study or have received active treatment with an investigational drug within 30 days or 5 half-lives of the investigational drug of Screening, whichever is longer
Clareo Health | A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism
